Patients’ Ability to Afford Lifesaving Drugs Is at Risk

Posted on

U.S. News & World Report —

Health insurers that want to discourage patients from choosing expensive medication therapies over less costly alternatives are targeting copay assistance programs, the coupons designed by drug manufacturers to help patients afford pricey medications their doctors believe will be most effective.

Copay assistance programs allow manufacturers and charity programs to assist patients with out-of-pocket costs. These programs give patients greater access to potentially lifesaving medications recommended by their doctors, irrespective of their full price. Since 2009, they have grown from under 100 to more than 700 offered today.

 

Read more here.